■ International Ophthalmology has published clinical data demonstrating the safety and effectiveness of the Omni Surgical System from Sight Sciences, Inc., as a minimally invasive, implant-free standalone procedure for pseudophakic glaucoma patients. Specifically, patients in the study had a history of iStent or iStent Inject (Glaukos) implants and their pressure was no longer controlled by the bypass stent plus IOP-lowering medications.

“The Omni Surgical System offers a potent implant-free procedure that I have found to be effective and durable in my pseudophakic patients where I had previously implanted trabecular bypass stents at the time of cataract surgery,” said Deepan Selvadurai, MD, an investigator for the study in practice at Buffalo Ophthalmology in New York. “This study showed that canaloplasty followed by trabeculotomy with Omni ... in pseudophakic eyes with stents was highly effective in reducing IOP,” he said in a company news release.